Synthaverse S.A.
Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally. It operates through BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anty-D 5… Read more
Market Cap & Net Worth: Synthaverse S.A. (SVE)
Synthaverse S.A. (WAR:SVE) has a market capitalization of $70.52 Million (zł293.23 Million) as of March 19, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #22839 globally and #145 in its home market, demonstrating a 4.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Synthaverse S.A.'s stock price zł3.87 by its total outstanding shares 75770575 (75.77 Million).
Synthaverse S.A. Market Cap History: 2015 to 2026
Synthaverse S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $38.09 Million to $70.52 Million (2.81% CAGR).
Synthaverse S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Synthaverse S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.15x
Synthaverse S.A.'s market cap is 1.15 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
10.91x
Synthaverse S.A.'s market cap is 10.91 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $38.09 Million | $42.59 Million | -$37.24 Million | 0.89x | N/A |
| 2016 | $20.77 Million | $36.34 Million | -$23.48 Million | 0.57x | N/A |
| 2017 | $26.60 Million | $31.40 Million | $588.00K | 0.85x | 45.25x |
| 2018 | $19.13 Million | $32.29 Million | -$32.41 Million | 0.59x | N/A |
| 2019 | $19.13 Million | $39.11 Million | $2.48 Million | 0.49x | 7.71x |
| 2020 | $163.27 Million | $40.16 Million | $4.44 Million | 4.07x | 36.78x |
| 2021 | $80.91 Million | $41.15 Million | $4.25 Million | 1.97x | 19.04x |
| 2022 | $109.15 Million | $50.38 Million | $6.08 Million | 2.17x | 17.95x |
| 2023 | $77.81 Million | $58.61 Million | $4.76 Million | 1.33x | 16.35x |
| 2024 | $82.37 Million | $71.76 Million | $7.55 Million | 1.15x | 10.91x |
Competitor Companies of SVE by Market Capitalization
Companies near Synthaverse S.A. in the global market cap rankings as of March 19, 2026.
Key companies related to Synthaverse S.A. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Synthaverse S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Synthaverse S.A.'s market cap moved from $38.09 Million to $ 70.52 Million, with a yearly change of 2.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł70.52 Million | +6.03% |
| 2025 | zł66.51 Million | -19.25% |
| 2024 | zł82.37 Million | +5.85% |
| 2023 | zł77.81 Million | -28.71% |
| 2022 | zł109.15 Million | +34.91% |
| 2021 | zł80.91 Million | -50.45% |
| 2020 | zł163.27 Million | +753.33% |
| 2019 | zł19.13 Million | 0.00% |
| 2018 | zł19.13 Million | -28.08% |
| 2017 | zł26.60 Million | +28.07% |
| 2016 | zł20.77 Million | -45.45% |
| 2015 | zł38.09 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Synthaverse S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.52 Million USD |
| MoneyControl | $70.52 Million USD |
| MarketWatch | $70.52 Million USD |
| marketcap.company | $70.52 Million USD |
| Reuters | $70.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.